Table 2.

ORs of ESA treatment response compared with other etiology, unadjusted and adjusted for confounders

EtiologyOR*95% CIP
Unadjusted model    
 CKD 4.20 0.962-18.3 .056 
 MDS 1.27 0.387-4.17 .693 
 AUE 3.24 0.849-12.4 .085 
Adjusted model, EPO linear†    
 CKD 3.60 0.815-15.9 .091 
 MDS 1.61 0.472-5.47 .448 
 AUE 3.30 0.838-13.0 .088 
 EPO <200 IU/L 9.28 1.14-75.4 .037 
EtiologyOR*95% CIP
Unadjusted model    
 CKD 4.20 0.962-18.3 .056 
 MDS 1.27 0.387-4.17 .693 
 AUE 3.24 0.849-12.4 .085 
Adjusted model, EPO linear†    
 CKD 3.60 0.815-15.9 .091 
 MDS 1.61 0.472-5.47 .448 
 AUE 3.30 0.838-13.0 .088 
 EPO <200 IU/L 9.28 1.14-75.4 .037 
*

OR of treatment response is relative to other etiology.

†

Includes only EPO level as a confounder. Sex, age, weight, comorbidity index, hemoglobin, eGFR, and presence of another cytopenia were not found to be statistically significant predictors of response.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal